propranolol has been researched along with Arterial Occlusive Diseases in 43 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Excerpt | Relevance | Reference |
---|---|---|
"The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 7.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
"To test the relative sensitivity of serotonin and propranolol pulmonary extraction measurements to changes in pulmonary vascular surface, we sequentially subjected anaesthetized dogs to left upper lobe atelectasis, left lung atelectasis and left pulmonary artery occlusion." | 7.67 | Effects of atelectasis and vascular occlusion on the simultaneous measurement of serotonin and propranolol pulmonary extraction in dogs. ( Dargent, F; Gardaz, JP; Junod, AF; Morel, P; Suter, PM, 1985) |
"The antiarrhythmic activity of the calcium entry blockers, verapamil, nifedipine and prenylamine, was assessed against arrhythmias occurring during 20 min of acute occlusion, or upon rapid reperfusion of the left anterior descending coronary artery (LAD) in anesthetized pigs." | 3.67 | Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol. ( Bergey, JL; McCallum, JD; Nocella, K; Wendt, RL, 1984) |
"To test the relative sensitivity of serotonin and propranolol pulmonary extraction measurements to changes in pulmonary vascular surface, we sequentially subjected anaesthetized dogs to left upper lobe atelectasis, left lung atelectasis and left pulmonary artery occlusion." | 3.67 | Effects of atelectasis and vascular occlusion on the simultaneous measurement of serotonin and propranolol pulmonary extraction in dogs. ( Dargent, F; Gardaz, JP; Junod, AF; Morel, P; Suter, PM, 1985) |
" The pre-treatment with a non-selective beta adrenoceptor blocker (propranolol) canceled all the isoxsuprine-dependent changes, while the pre-treatment with a selective beta adrenoceptor blocker (metoprolol) abolished only tachycardia and did not influence the increase of calf blood flow and the decrease of blood viscosity." | 3.66 | Influence of non-selective and selective beta adrenoceptor blockade on isoxsuprine-dependent hemodynamic and rheologic changes. ( Acciavatti, A; Cappelli, R; Di Perri, T; Forconi, S; Guerrini, M; Pecchi, S; Pieragalli, D, 1981) |
"The effect of celiprolol at a daily dosage of 300 mg (19 patients) was compared with that of propranolol at a daily dosage of 120 mg (14 patients) on peripheral blood flow of the calf and foot in a randomized double-blind trial." | 2.66 | [Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease]. ( Klieber, M; Resch, F, 1986) |
" Medical treatment should be considered a failure only if maximal dosage of nitrates and beta blockers is attained without satisfactory control of symptoms." | 2.36 | What is optimal drug therapy in angina pectoris? ( Brest, AN; Frankl, WS, 1983) |
"Propranolol has no observable effect on coronary collateral development despite its acknowledged ability to prevent or attenuate myocardial ischaemia." | 1.29 | Lack of effect of propranolol on canine coronary collateral development during progressive coronary stenosis and occlusion. ( Cohen, MV, 1993) |
"Propranolol was administered to 18 arteriopathic patients before the exercise to ascertain whether the reverse situation can be induced." | 1.26 | Protective effects of propranolol on the exercise-induced reduction of blood flow in arteriopathic patients. ( Brevetti, G; Chiariello, M; Condorelli, M; Lavecchia, G; Paudice, G; Rengo, F, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 40 (93.02) | 18.7374 |
1990's | 3 (6.98) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Walinsky, P | 1 |
Santamore, W | 1 |
Wiener, L | 1 |
Cho, SY | 1 |
Brest, AN | 2 |
Vlahakes, GJ | 1 |
Baer, RW | 1 |
Uhlig, PN | 1 |
Verrier, ED | 1 |
Bristow, JD | 1 |
Hoffmann, JI | 1 |
Frankl, WS | 1 |
Thandroyen, FT | 1 |
Worthington, MG | 1 |
Higginson, LM | 1 |
Opie, LH | 1 |
Agerskov, K | 2 |
Winterfeld, HJ | 1 |
Strangfeld, D | 1 |
Siewert, H | 1 |
Schmidt, HH | 1 |
Mederacke, W | 1 |
Crozatier, B | 1 |
Caillet, D | 1 |
Bical, O | 1 |
Hintze, TH | 1 |
Vatner, SF | 1 |
Vetterlein, F | 1 |
Schmidt, G | 1 |
Bergey, JL | 1 |
Wendt, RL | 1 |
Nocella, K | 1 |
McCallum, JD | 1 |
Benfey, BG | 1 |
Elfellah, MS | 1 |
Ogilvie, RI | 1 |
Varma, DR | 1 |
Pang, JA | 1 |
Blackburn, JP | 1 |
Butland, RJ | 1 |
Corrin, B | 1 |
Williams, TR | 1 |
Geddes, DM | 1 |
Ngai, JH | 1 |
Yabuuchi, Y | 1 |
Schwartz, A | 1 |
Millard, RW | 1 |
Russell, RO | 1 |
Rogers, WJ | 1 |
Mantle, JA | 1 |
Kouchoukos, NT | 1 |
Karp, RB | 1 |
Oberman, A | 1 |
Charles, ED | 1 |
Kronenfeld, JJ | 1 |
Wayne, J | 1 |
Rackley, CE | 1 |
Resnekov, L | 1 |
Wolk, M | 1 |
Rosati, RA | 1 |
Conti, CR | 1 |
Becker, LC | 2 |
Hutter, AM | 1 |
Biddle, TL | 1 |
Schroeder, JC | 1 |
Kaplan, EM | 1 |
Gilbert, JP | 1 |
Frommer, PL | 1 |
Mock, MB | 1 |
Brevetti, G | 3 |
Chiariello, M | 2 |
Ferulano, GP | 1 |
Betocchi, S | 1 |
Paudice, G | 3 |
Lavecchia, G | 3 |
Abate, S | 1 |
Verrienti, S | 1 |
Condorelli, M | 2 |
Di Perri, T | 1 |
Forconi, S | 1 |
Guerrini, M | 1 |
Pecchi, S | 1 |
Pieragalli, D | 1 |
Cappelli, R | 1 |
Acciavatti, A | 1 |
Diehm, C | 1 |
Comberg, HU | 1 |
Ey, A | 1 |
Mörl, H | 1 |
Schettler, G | 1 |
Kumada, T | 1 |
Gallagher, KP | 1 |
Shirato, K | 1 |
McKown, D | 1 |
Miller, M | 1 |
Kemper, WS | 1 |
White, F | 1 |
Ross, J | 1 |
Hollenberg, M | 1 |
Budge, WR | 1 |
Wisneski, JA | 1 |
Gertz, EW | 1 |
Serizawa, T | 1 |
Carabello, BA | 1 |
Grossman, W | 1 |
Cohen, MV | 1 |
Gutterman, DD | 1 |
Goodson, A | 1 |
De Caprio, L | 1 |
Ferro, G | 1 |
D'Ascia, C | 1 |
Orefice, U | 1 |
Hillis, LD | 1 |
Khuri, SF | 1 |
Braunwald, E | 1 |
Kloner, RA | 1 |
Tow, D | 1 |
Barsamian, E | 1 |
Maroko, PR | 1 |
Peduzzi, P | 1 |
Hultgren, HN | 1 |
O'rourke, RA | 1 |
Schnitzler, RN | 1 |
Miura, M | 1 |
Thomas, R | 1 |
Ganz, W | 1 |
Sokol, T | 1 |
Shell, WE | 2 |
Toshimitsu, T | 1 |
Kwan, AC | 1 |
Singh, BN | 1 |
Rengo, F | 1 |
KU, DD | 1 |
Lucchesi, BR | 1 |
Teplov, SI | 1 |
Balueva, TV | 1 |
Thorén, PN | 1 |
Hykin, PG | 1 |
Gartry, D | 1 |
Brazier, DJ | 1 |
Graham, E | 1 |
Klieber, M | 1 |
Resch, F | 1 |
Katz, B | 1 |
Hara, Y | 1 |
Ichihara, K | 1 |
Abiko, Y | 1 |
Miyazawa, K | 1 |
Fukuyama, H | 1 |
Komatsu, E | 1 |
Yamaguchi, I | 1 |
Lima, JA | 1 |
Melin, JA | 1 |
Lima, S | 1 |
Kallman, CA | 1 |
Weisfeldt, ML | 1 |
Weiss, JL | 1 |
Dargent, F | 1 |
Gardaz, JP | 1 |
Morel, P | 1 |
Suter, PM | 1 |
Junod, AF | 1 |
Sturm, A | 1 |
Machida, K | 1 |
Kleiger, RE | 1 |
Martin, T | 1 |
Lavelle, JF | 1 |
Covell, JW | 1 |
Sobel, BE | 1 |
2 reviews available for propranolol and Arterial Occlusive Diseases
Article | Year |
---|---|
What is optimal drug therapy in angina pectoris?
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arterial Occlusive Diseases; Calcium Channel Blockers; | 1983 |
On the nervous control of collateral arterial tone in the human lower limb with large artery obstruction during postural change.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Blood Flow V | 1984 |
2 trials available for propranolol and Arterial Occlusive Diseases
Article | Year |
---|---|
[Behavior of blood pressure and peripheral hemodynamics in interval therapy in untreated and propranolol-treated patients with arterial circulatory disorders of the lower extremities].
Topics: Adult; Aged; Arterial Occlusive Diseases; Blood Pressure; Combined Modality Therapy; Hemodynamics; H | 1984 |
[Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease].
Topics: Aged; Arterial Occlusive Diseases; Blood Pressure; Celiprolol; Foot; Humans; Hypertension; Leg; Midd | 1986 |
39 other studies available for propranolol and Arterial Occlusive Diseases
Article | Year |
---|---|
Effect of norepinephrine on coronary hemodynamics in coronary stenotic canine model.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Blo | 1980 |
Adrenergic influence in the coronary circulation of conscious dogs during maximal vasodilation with adenosine.
Topics: Adenosine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Ani | 1982 |
The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Ate | 1983 |
Effect of propranolol on the tone of collateral arteries in patients with occlusion of the superficial femoral artery.
Topics: Arterial Occlusive Diseases; Collateral Circulation; Humans; Muscle Tonus; Posture; Propranolol; Vas | 1983 |
Left ventricular adaptation to sustained pressure overload in the conscious dog.
Topics: Animals; Aortic Diseases; Arterial Occlusive Diseases; Blood Pressure; Dogs; Hemodynamics; Myocardia | 1984 |
Reactive dilation of large coronary arteries in conscious dogs.
Topics: Aminophylline; Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Circulation; Coronary | 1984 |
Effects of propranolol and epinephrine on density of capillaries in rat heart.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Capillaries; Coronary Vessels; Epinephrine; He | 1984 |
Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
Topics: Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Calcium Channel Blockers | 1984 |
Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Dogs; Drug Therapy, Combinat | 1984 |
Propranolol uptake by dog lung: effect of pulmonary artery occlusion and shock lung.
Topics: Animals; Arterial Occlusive Diseases; Arteries; Carbon Dioxide; Cardiac Output; Dogs; Dose-Response | 1982 |
Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
Topics: Adenosine; Animals; Arterial Occlusive Diseases; Benzazepines; Coronary Circulation; Coronary Diseas | 1983 |
Management of unstable angina pectoris.
Topics: Angina Pectoris; Arterial Occlusive Diseases; Cardiac Surgical Procedures; Coronary Artery Bypass; C | 1981 |
Propranolol-induced reverse vascular steal in arteriopathic patients.
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Blood Flow Velocity; Blood Pressure; Femoral Ar | 1982 |
Influence of non-selective and selective beta adrenoceptor blockade on isoxsuprine-dependent hemodynamic and rheologic changes.
Topics: Adult; Arterial Occlusive Diseases; Blood Flow Velocity; Blood Pressure; Drug Interactions; Female; | 1981 |
[Peripheral arterial vasoocclusive disease: no absolute contraindication to beta receptor blockers (author's transl)].
Topics: Arterial Occlusive Diseases; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol | 1981 |
Reduction of exercise-induced regional myocardial dysfunction by propranolol. Studies in a canine model of chronic coronary artery stenosis.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Chronic Disease; Coronary Disease; Coronary Ve | 1980 |
Treadmill score quantifies electrocardiographic response to exercise and improves test accuracy and reproducibility.
Topics: Adult; Aged; Arterial Occlusive Diseases; Coronary Disease; Electrocardiography; Exercise Test; Fals | 1980 |
Effect of pacing-induced ischemia on left ventricular diastolic pressure-volume relations in dogs with coronary stenoses.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Blood Volume; Cardiac Pacing, Artificial; Cor | 1980 |
Lack of effect of propranolol on canine coronary collateral development during progressive coronary stenosis and occlusion.
Topics: Animals; Arterial Occlusive Diseases; Blood Flow Velocity; Collateral Circulation; Coronary Disease; | 1993 |
Role of parabrachial nucleus in baroreflex-mediated coronary vasoconstriction.
Topics: Animals; Arterial Occlusive Diseases; Baroreflex; Blood Pressure; Carotid Artery Diseases; Cats; Cor | 1996 |
[Regional hemodynamic changes induced by muscular exercise in subjects with obliterating arteriopathy of the lower extremities: effect of beta receptor blocking].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Female; Humans; Intermittent Claudication; | 1977 |
Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog.
Topics: Animals; Arterial Occlusive Diseases; Carbon Dioxide; Coronary Disease; Coronary Vessels; Dogs; Drug | 1979 |
Effect of medical vs surgical treatment on symptoms in stable angina pectoris. The Veterans Administration Cooperative Study of surgery for coronary arterial occlusive disease.
Topics: Angina Pectoris; Arterial Occlusive Diseases; Coronary Vessels; Evaluation Studies as Topic; Humans; | 1979 |
Angina pectoris: an overview.
Topics: Angina Pectoris; Angina Pectoris, Variant; Arterial Occlusive Diseases; Blood Pressure; Coronary Art | 1977 |
The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs.
Topics: Animals; Arterial Occlusive Diseases; Cardiac Output; Coronary Vessels; Dogs; Electrocardiography; H | 1979 |
Protective effects of propranolol on the exercise-induced reduction of blood flow in arteriopathic patients.
Topics: Arterial Occlusive Diseases; Blood Pressure; Exercise Test; Female; Heart Rate; Humans; Male; Middle | 1979 |
Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
Topics: Animals; Arterial Occlusive Diseases; Creatine Kinase; Dogs; Electrocardiography; Heart Injuries; He | 1978 |
[Changes in coronary circulation following reflex excitation of the sympathetic nervous system].
Topics: Animals; Arterial Occlusive Diseases; Atropine; Blood Pressure; Carotid Artery Diseases; Carotid Sin | 1978 |
Characteristics of left ventricular receptors with nonmedullated vagal afferents in cats.
Topics: Animals; Aortic Diseases; Arterial Occlusive Diseases; Blood Pressure; Blood Transfusion; Cats; Hear | 1977 |
Bilateral cilio-retinal artery occlusion in classic migraine.
Topics: Adult; Arterial Occlusive Diseases; Ciliary Body; Female; Fluorescein Angiography; Humans; Migraine | 1991 |
Migrainous central retinal artery occlusion.
Topics: Adult; Arterial Occlusive Diseases; Humans; Male; Migraine Disorders; Propranolol; Retinal Artery; R | 1986 |
MCl-176, a novel calcium channel blocker, attenuates the ischemic myocardial acidosis induced by coronary artery occlusion in dogs.
Topics: Acidosis; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Coronary Vessels; Dogs; Fe | 1988 |
Effects of propranolol on myocardial damage resulting from coronary artery occlusion followed by reperfusion.
Topics: Animals; Arterial Occlusive Diseases; Calcium; Creatine Kinase; Dogs; Hemodynamics; Lactates; Lactic | 1986 |
Impaired thickening of nonischemic myocardium during acute regional ischemia in the dog.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Coronary Circulation; Coronary Disease; Diastol | 1985 |
Effects of atelectasis and vascular occlusion on the simultaneous measurement of serotonin and propranolol pulmonary extraction in dogs.
Topics: Animals; Arterial Occlusive Diseases; Dogs; Female; Indocyanine Green; Lung; Male; Propranolol; Pulm | 1985 |
[Letter: Peripheral blood circulation disorders due to beta receptor blockers?].
Topics: Adrenergic beta-Antagonists; Arterial Occlusive Diseases; Humans; Oxprenolol; Propranolol; Raynaud D | 1974 |
The changes of left and right ventricular volumes induced by propranolol and subsequent carotid occlusion.
Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Cardiac Output; Cardiac Volume; Carotid Artery | 1972 |
The patient with angina. Medical management plus sympathetic, continuous care.
Topics: Angina Pectoris; Arterial Occlusive Diseases; Carotid Body; Coronary Vessels; Drug Synergism; Electr | 1973 |
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Arteries; Coronary Vessels; Creatine Kinase; Do | 1973 |